# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001564590-20-005048
Filing Date
2020-02-18
Accepted
2020-02-18 16:36:06
Documents
25
Period of Report
2020-02-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | abio-8k_20200218.htm | 8-K | 37638
2 | EX-99.1 | abio-ex991_7.htm | EX-99.1 | 107317
3 | EX-99.2 | abio-ex992_19.htm | EX-99.2 | 25186
4 | GRAPHIC | gdighdpznlyt000011.jpg | GRAPHIC | 313529
5 | GRAPHIC | gdighdpznlyt000012.jpg | GRAPHIC | 352266
6 | GRAPHIC | gdighdpznlyt000018.jpg | GRAPHIC | 269467
7 | GRAPHIC | gdighdpznlyt000008.jpg | GRAPHIC | 244056
8 | GRAPHIC | gdighdpznlyt000013.jpg | GRAPHIC | 426555
9 | GRAPHIC | gdighdpznlyt000019.jpg | GRAPHIC | 329273
10 | GRAPHIC | gdighdpznlyt000020.jpg | GRAPHIC | 148776
11 | GRAPHIC | gdighdpznlyt000005.jpg | GRAPHIC | 365426
12 | GRAPHIC | gdighdpznlyt000004.jpg | GRAPHIC | 311516
13 | GRAPHIC | gdighdpznlyt000009.jpg | GRAPHIC | 251736
14 | GRAPHIC | gdighdpznlyt000007.jpg | GRAPHIC | 315983
15 | GRAPHIC | gdighdpznlyt000014.jpg | GRAPHIC | 422913
16 | GRAPHIC | gdighdpznlyt000016.jpg | GRAPHIC | 321222
17 | GRAPHIC | gdighdpznlyt000001.jpg | GRAPHIC | 476671
18 | GRAPHIC | gdighdpznlyt000017.jpg | GRAPHIC | 318527
19 | GRAPHIC | gdighdpznlyt000015.jpg | GRAPHIC | 279172
20 | GRAPHIC | gdighdpznlyt000002.jpg | GRAPHIC | 517877
21 | GRAPHIC | gdighdpznlyt000006.jpg | GRAPHIC | 253051
22 | GRAPHIC | gdighdpznlyt000003.jpg | GRAPHIC | 332137
23 | GRAPHIC | gdighdpznlyt000021.jpg | GRAPHIC | 466711
24 | GRAPHIC | gdighdpznlyt000010.jpg | GRAPHIC | 356674
25 | GRAPHIC | gvfmwwhps3wa000001.jpg | GRAPHIC | 20861
| Complete submission text file | 0001564590-20-005048.txt |  | 9943993

Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 20625842
SIC: 2835 In Vitro & In Vivo Diagnostic Substances